All Marketing Authorizing Holders (MAHs) of medicines are hereby informed that the following New/RR/Renewal application (lists are attached), which remain pending at the pricing division due to non-response to price request details within three months from the initial communication from the NMRA, will be considered for rejection from both the pricing review process and the registration process at the NMRA.

Allow 2 weeks grace period from the date of this notice and if no response is received a notification letter will be issued to inform the withdrawal and closure of these applications and applicants can submit any concerns or clarification regarding this decision within one month of this letter. Failure to respond within this period will result in the permanent rejection of your application by the NMRA.

 Please note that after rejection, if the applicants wish to proceed further, these product registration applications must be resubmitted as a new application to the NMRA

‍